99 related articles for article (PubMed ID: 10560792)
1. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
Sumino H; Ichikawa S; Kanda T; Sakamaki T; Nakamura T; Sato K; Kobayashi I; Nagai R
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women.
Nogawa N; Sumino H; Ichikawa S; Kumakura H; Takayama Y; Nakamura T; Kanda T; Mizunuma H; Kurabayashi M
Menopause; 2001; 8(3):210-5. PubMed ID: 11355044
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype.
Sumino H; Ichikawa S; Ohyama Y; Nakamura T; Kanda T; Sakamoto H; Sakamaki T; Mizunuma H; Kurabayashi M
Hypertens Res; 2003 Jan; 26(1):53-8. PubMed ID: 12661913
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
[TBL] [Abstract][Full Text] [Related]
5. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women.
Miya Y; Sumino H; Ichikawa S; Nakamura T; Kanda T; Kumakura H; Takayama Y; Mizunuma H; Sakamaki T; Kurabayashi M
Hypertens Res; 2002 Mar; 25(2):153-9. PubMed ID: 12047028
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.
Tamama K; Sumino H; Ichikawa S; Kanda T; Kotajima N; Fukumura Y; Kurabayashi M; Murakami M
J Hypertens; 2003 Jun; 21(6):1151-6. PubMed ID: 12777952
[TBL] [Abstract][Full Text] [Related]
10. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
Sumino H; Ichikawa S; Sawada Y; Sakamoto H; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
Thromb Res; 2005; 115(5):359-66. PubMed ID: 15733968
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women.
Proudler AJ; Ahmed AI; Crook D; Fogelman I; Rymer JM; Stevenson JC
Lancet; 1995 Jul; 346(8967):89-90. PubMed ID: 7603219
[TBL] [Abstract][Full Text] [Related]
14. Effects of hormone replacement therapy on office and ambulatory blood pressure in Japanese hypertensive postmenopausal women.
Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kanda T; Sakamaki T; Kurabayashi M
Hypertens Res; 2003 May; 26(5):369-76. PubMed ID: 12887127
[TBL] [Abstract][Full Text] [Related]
15. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women.
Proudler AJ; Cooper A; Whitehead M; Stevenson JC
Clin Endocrinol (Oxf); 2003 Jan; 58(1):30-5. PubMed ID: 12519409
[TBL] [Abstract][Full Text] [Related]
16. Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes.
Manwaring P; Phoon S; Diamond T; Howes LG
Maturitas; 2002 Nov; 43(3):157-64. PubMed ID: 12443833
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
[TBL] [Abstract][Full Text] [Related]
18. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.
Hayward CS; Samaras K; Campbell L; Kelly RP
Am J Hypertens; 2001 Jul; 14(7 Pt 1):699-703. PubMed ID: 11465656
[TBL] [Abstract][Full Text] [Related]
20. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels.
Koh KK; Son JW; Ahn JY; Lee SK; Hwang HY; Kim DS; Jin DK; Ahn TH; Shin EK
Int J Cardiol; 2001 Nov; 81(1):43-50. PubMed ID: 11690664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
